Markets

Insider Trading

Hedge Funds

Retirement

Opinion

25 Most Cannabis Consuming-Countries in the World

In this article, we are going to discuss the 25 most cannabis-consuming countries in the world. You can skip our detailed analysis of the global cannabis industry, the budding cannabis-based pharmaceutical industry and the interest of big pharma, and the offshore business activities of some US-based cannabis companies, and go directly to 10 Most Cannabis Consuming-Countries in the World

The medicinal properties of the cannabis plant have been known for millennia. The first documented case of its use dates back to 2,800 B.C., when it was listed in Emperor Shen Nung’s (regarded as the father of Chinese medicine) pharmacopeia. Cannabis is named as one of the five most sacred plants on earth in Hinduism and is believed to cleanse sins and unite one with Shiva. It is also revered for its medicinal properties and used in Ayurvedic medicine. 

Global Cannabis Industry: 

As we mentioned in our article – Top 20 Countries Where Weed Is Legal In 2023 – the global cannabis market was valued at $47.32 billion in 2022, and is projected to grow from $57.18 billion in 2023 to $444.34 billion by 2030, growing at a CAGR of 34% during the forecast period. 

Marijuana legalization is gaining momentum around the globe, driven primarily by the increasing recognition that the product may have a range of legitimate medicinal benefits and therapeutic applications. It is the most widely cultivated, trafficked, and consumed drug worldwide. 

Cannabis-Based Pharmaceutical Industry: 

The FDA understands that there is increasing interest in the potential utility of cannabis for a variety of medical conditions. In 2018, the federal watchdog approved the country’s first-ever drug derived from marijuana – Epidiolex. Produced by GW Pharmaceuticals, the drug is used to treat two rare forms of epilepsy. 

The $7.2 billion acquisition of GW Pharmaceuticals by the global biopharma giant Jazz Pharmaceuticals plc (NASDAQ:JAZZ) in 2021 is the latest sign of the growing legitimacy and increased receptivity of cannabis-based drugs in the pharma industry. With the new purchase, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) – which has focused primarily on sleep medications and oncology – has augmented its neuroscience portfolio. Net product sales of Epidiolex reached $746.4 million in 2022 – an increase of 12% from the previous year – according to an announcement by Jazz Pharmaceuticals plc (NASDAQ:JAZZ). 

Pfizer Inc. (NYSE:PFE) has also entered the medical cannabis industry, betting on a promising cannabinoid-based bowel disease treatment. In December 2021, Pfizer Inc. (NYSE:PFE) announced the acquisition of the clinical-stage company Arena Pharmaceuticals for a total equity value of around $6.7 billion. By acquiring all shares of Arena for $100 per share in an all-cash transition, Pfizer Inc. (NYSE:PFE) has joined other big pharma companies in the cannabis space. 

Offshore Business Activities:  

The United States of America is a behemoth of the global cannabis industry, so much so that even just one of its states – California – is the single largest cannabis market in the world. Americans love a good buzz and they’re forking over big bucks for it. This provides a huge opportunity for companies and entrepreneurs everywhere, who want the lion’s share of the sweet green ganja pie and are thus coming up with more and more innovative solutions to bring about a paradigm shift in the industry. Large and mature consumer markets like LA and Chicago act as testing grounds for such innovators to test their ideas, before they bring them to the rest of the country and even across the border. 

A great example is Curaleaf Holdings, Inc. (OTC:CURLF) – a Massachusetts-based leading medical and recreational cannabis company serving over 350,000 registered customers across 23 states in the country. Curaleaf has worked to introduce new products in the American market, including the vape hardware system Cliq by Select, Select X Bites gummies, and even a cannabis-infused Seltzer brand. The company also maintains a presence in the U.K. and Germany – two of the countries that consume the most weed in Europe. Since Germany is in the process of drafting its adult-use cannabis framework, Curaleaf Holdings, Inc. (OTC:CURLF) has already acquired a majority stake in the local pharmaceutical company Four 20 Pharma, thus positioning itself to take advantage of the upcoming adult-use opportunities. The company also anticipates that more countries will follow Germany’s lead in the coming years and adopt more liberal adult-use regulations. 

Similarly, Tilray Brands, Inc. (NASDAQ:TLRY) is a leading cannabis lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. Headquartered in New York, Tilray is one of the leading global companies in the production and research of medical cannabis. It was announced last year that the industry giant’s medical cannabis division, Tilray Medical and FL Group, has received authorization from Italy’s Ministry of Health to distribute three new medical cannabis compounds to pharmacies across Italy, further broadening its portfolio of pharmaceutical grade cannabis offerings. Tilray Brands, Inc. (NASDAQ:TLRY) also announced a new strategic partnership with Pharmaidea, a Petrone Group company, to market and educate over 12,000 pharmacies across Italy on the benefits of medical cannabis and medical cannabis patient care.

Both, Curaleaf Holdings, Inc. (OTC:CURLF) and Tilray Brands, Inc. (NASDAQ:TLRY), rank among the Biggest Marijuana Companies in the World

With that said, here are the Countries that Smoke the Most Weed in 2024

A close-up shot of a cannabis plant, showing its intricate details.

Methodology:

To collect data for this article, we have referred to the UNODC World Drug Report, to determine Countries with the Highest Annual Prevalence of Cannabis Use. The annual prevalence is the percentage of the youth and adult population who have consumed cannabis at least once in the past survey year. To make sure our list is up-to-date, we have only included countries with data available from 2013 and onwards. 

By the way, Insider Monkey is an investing website that tracks the movements of corporate insiders and hedge funds. By using a similar consensus approach, we identify the best stock picks of more than 900 hedge funds investing in US stocks. The top 10 consensus stock picks of hedge funds outperformed the S&P 500 Index by more than 140 percentage points over the last 10 years (see the details here). Whether you are a beginner investor or professional one looking for the best stocks to buy, you can benefit from the wisdom of hedge funds and corporate insiders.

A close-up shot of a cannabis plant, showing its intricate details.

25. North Macedonia

Annual Prevalence of Cannabis Use: 6.6%

In March 2016, North Macedonia legalized growing cannabis for medical purposes and to refine, extract, and produce hemp seed and cannabis oil. This has been a boon to the country’s economy worth an estimated $108.5 million per year that has attracted both local and foreign investors. 

Since 2016, authorities in North Macedonia have issued more than 60 licenses to cultivate medical cannabis, however, the recreational use of marijuana is still illegal. 

24. Belgium

Annual Prevalence of Cannabis Use: 7%

Cannabis is illegal for recreational use in Belgium. However, simple possession of up to 3 grams has been largely decriminalized and will likely result in a mere fine.

However, there has recently been a great push to legalize ganja for personal use in the Western European country. Belgium Deputy Prime Minister and Minister of the Economy and Employment Pierre-Yves Dermagne recently endorsed modernizing his country’s cannabis policies to permit adult-use marijuana, stating that his country ‘must end the hypocrisy’. Philippe Close, the socialist mayor of Brussels, has also urged the creation of cannabis cafés on the lines of Amsterdam. 

Belgium is placed among the Countries with the Highest Rate of Cannabis Use

23. Germany

Annual Prevalence of Cannabis Use: 7.09%

Germany is among the latest countries to approve a plan to liberalize rules on cannabis, setting the scene for E.U.’s most populous nation to decriminalize possession of limited amounts and allow members of ‘cannabis clubs’ to buy the substance for recreational use. If all goes well and there are no more delays, the legalization of cannabis possession and cultivation will take effect on April 1st, 2024. 

With an annual consumption of 12.9 metric tons, Hamburg is one of the Most Cannabis-Consuming Cities in the World

22. Ireland

Annual Prevalence of Cannabis Use: 7.1%

Cannabis is illegal for recreational purposes in Ireland, while its use for medical purposes requires case-by-case approval by the Health Ministry. 

Nevertheless, Ireland is among the countries that smoke the most weed in Europe. Around 17% of Irish people now use products containing cannabis, according to a 2021 survey by Eurobarometer

21. Liberia

Annual Prevalence of Cannabis Use: 7.52%

Per Liberian law, cannabis possession, use, cultivation, and sale are illegal for medical or recreational use. However, due to underfunded law enforcement and corruption, the plant is grown widely across the country. 

Cannabis is the most commonly used drug in Liberia and its consumption is also popular among adolescents, with around 9% having used it in the past.

20. Switzerland

Annual Prevalence of Cannabis Use: 7.7%

Decades after pioneering prescription heroin and safe injection sites, Switzerland is now experimenting with decriminalizing recreational cannabis. It’s being done in a very Swiss way – taking things slow and steady to see how the population responds.

The federal government has now authorized trials to take place over the coming decade to experiment with decriminalizing recreational cannabis, taking small steps like it did for four years before introducing prescribed heroin in the 1990s.

19. Argentina

Annual Prevalence of Cannabis Use: 8.13%

While possession of small amounts of weed is decriminalized in Argentina, the cultivation, distribution, and sale of cannabis remains illegal. The country has taken steps towards legalizing cannabis for medical purposes, and some provinces have also decriminalized the use of the drug for personal use.

18. Finland

Annual Prevalence of Cannabis Use: 8.2%

Nearly 30% of adults in Finland admitted to having tried illicit drugs at some point in their lives, most commonly cannabis. Helsinki ranks among Cities with the Most Expensive Weed in the World

17. Croatia

Annual Prevalence of Cannabis Use: 10.2%

The most used drug in Croatia is cannabis, followed by cocaine, and amphetamines. According to a survey by the Sewage Analysis CORE Group Europe (SCORE) in 2021, the daily cannabis consumption in Zagreb was 132.9 mg per 1,000 people. 

16. Italy

Annual Prevalence of Cannabis Use: 10.21%

At present, cannabis is legal in Italy for medical and industrial uses – although it is strictly regulated – while it is decriminalized for recreational use. Over the course of 2021, approximately 17.7% of high school students in Italy consumed cannabis, with this figure reaching 20% when considering only male students.  

Rome ranks among the Cities with the Highest Weed Consumption in the World

15. Netherlands

Annual Prevalence of Cannabis Use: 10.4%

Cannabis has been available for recreational use in Dutch coffee shops since 1976. Amsterdam has dominated cannabis tourism for 40 years, but now it’s stepping back from this multibillion-dollar industry. Amsterdam Mayor Femke Halsema announced last year that marijuana tourism is a blight on the city, fostering crime and public disorder, and proposed banning foreigners from its cannabis cafés.  

The Dutch rank among the top weed smokers in the world

14. Monaco

Annual Prevalence of Cannabis Use: 10.47%

Monaco has very stern cannabis laws. Theoretically, individuals in possession of small quantities of marijuana are liable to a fine whereas bigger quantities are subject to jail terms and hefty fines. However, in practice, officers often fail to execute these laws especially in cases where the amount of cannabis is significantly small. It often gets waved aside as a misdemeanor. This has led to many people feeling relaxed to smoke weed in Monaco.

13. Morocco

Annual Prevalence of Cannabis Use: 10.47%

Morocco has long been ranked as one of the world’s largest cannabis producers. In June 2021, the country’s Parliament adopted a law to regularize the plant’s production for medical, cosmetic, and industrial purposes, while production and consumption for recreational purposes remained strictly prohibited.

Morocco creates a considerable amount of the world’s hashish and was the top producer of the resin from 2002 to 2010.

12. Spain

Annual Prevalence of Cannabis Use: 10.5%

In Madrid, cannabis clubs aren’t strictly legal. Instead, they operate in a legal gray area in which ‘members’ join clubs and ‘share’ cannabis that they grow. ‘Donations’ are exchanged for tokens, which are then used to purchase products.  

With an average price per gram of $6.8, Madrid ranks among the Cities with the Cheapest Weed in the World

11. Nigeria

Annual Prevalence of Cannabis Use: 10.76%

Cannabis is cultivated and produced in Nigeria for both domestic consumption and export. The cannabis produced in Nigeria feeds its large domestic market (an estimated 10.6 million cannabis users in 2018) and there is evidence for trafficking to other countries in Africa, too. In the past decade, a number of countries outside of Africa also have mentioned Nigeria as the source country of cannabis.

Nigeria is the Country that Consumes the Most Weed in Africa

Click to continue reading and see the 10 Most Cannabis Consuming-Countries in the World

Suggested Articles:

Disclosure: None. 25 Most Cannabis Consuming-Countries in the World is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

This is the #1 Gold Stock for your 2025 watch list

Brace yourself.

There’s no question that thanks to Washington’s disastrous policies – and out-of-control spending – the outlook for the U.S. economy now appears dire.

And with the U.S. national debt now rising by a staggering $1 trillion every 100 days…there are no easy solutions to help get the nation back on track.

While Jay Powell and the Biden-Harris White House sweat out a federal debt that has reached $35.5 trillion – and climbing – many investors have raced to the sidelines with their cash.

But the truly savvy investors laugh while Jay Powell frets, because they understand that this ridiculous spending has also triggered a nearly unprecedented bull market for gold.

Just look at this chart for the yellow metal.

After testing the $2,000/ounce mark in August 2020 and February 2022, gold traded down to near $1,600/ounce in October 2022.

Since then, gold prices have been on an absolute tear and currently sit above $2,600/ounce, a $1,000/oz increase in just two short years.

But the surge in gold prices that we’ve seen over the past few years could pale in comparison to what’s on the horizon. As shocking as it may sound, with no end in sight for the Fed’s money printing, we could see the price of gold increase by many multiples in the years ahead.

With soaring inflation, the dollar stands to lose more and more of its value, which means you’ll need a lot more dollars to buy gold.

According to legendary investor Peter Schiff, today’s seemingly-high gold price of $2,600/oz. “could soar to $26,000/oz. — or even $100,000/oz. There’s no limit because gold isn’t changing — it’s the value of the dollar that’s decreasing.”[i]

Meanwhile, as profitable as gold has been, select gold mining stocks have really kicked into high gear, handing investors even bigger profits.

Click to continue reading…